Genetic and environmental factors in cutaneous malignant melanoma

Biochimie
Brigitte Bressac-de-PailleretsFlorence Demenais

Abstract

Cutaneous malignant melanoma (CMM) is an interesting example of multifactorial disease, where both genetic and environmental factors are involved and interact. Major risk factors include a personal and familial history of melanoma, cutaneous and pigmentary characteristics, sun exposure and reactions to sun exposure. Phenotypic risk factors are likely to be genetically determined. Two high-risk melanoma susceptibility genes-CDKN2A and CDK4-have been identified to date, with a third gene p14(ARF) also being suspected of playing a role. Other high-risk genes are anticipated by the existence of 9p21-unlinked families. A low-risk melanoma-susceptibility gene-MC1R-has also been identified. Current studies aim to identify other susceptibility genes as well as to determine the respective contributions and interactions of the various genetic and environmental factors of CMM and associated phenotypes.

References

Nov 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·J W FountainJ Lahti
Nov 13, 1992·Science·L A Cannon-AlbrightA E Bale
Dec 4, 1991·Journal of the National Cancer Institute·D E GoldgarM H Skolnick
Oct 1, 1995·Archives of Dermatology·F GrangeM F Avril
Oct 12, 1995·The New England Journal of Medicine·A M GoldsteinW H Clark
Dec 1, 1994·Human Molecular Genetics·C MacGeochN K Spurr
Dec 3, 1994·Lancet·S L HarrisonI Wronski
Dec 10, 1994·Lancet·D BattistuttaN Hayward
Sep 1, 1994·Nature Genetics·C J HussussianN C Dracopoli
Dec 1, 1993·Melanoma Research·B K Armstrong, A Kricker
Sep 1, 1996·Acta Oto-laryngologica·U Ringborg
Mar 1, 1997·Current Opinion in Oncology·M Berwick, A Halpern
Nov 5, 1997·Journal of the National Cancer Institute·D C WhitemanN K Hayward
Mar 27, 1998·The New England Journal of Medicine·J MonzonN J Lassam
Aug 8, 1998·The New England Journal of Medicine·J C Bystryn
Aug 8, 1998·The New England Journal of Medicine·R C WachsmuthJ A Bishop
Mar 10, 1999·Journal of the National Cancer Institute·J AitkenN Hayward
Jul 1, 1999·Genes & Development·C J Sherr, J M Roberts
Oct 28, 1999·The Journal of Investigative Dermatology. Symposium Proceedings·I SuzukiZ Abdel-Malek
Apr 25, 2000·Oncogene·M G ShennanN Lassam
Jun 28, 2000·American Journal of Human Genetics·P CiottiA M Goldstein
Jan 4, 2001·Human Molecular Genetics·J A Randerson-MoorD T Bishop
Aug 14, 2001·American Journal of Human Genetics·N F BoxN K Hayward
Aug 14, 2001·American Journal of Human Genetics·P A van der VeldenN A Gruis
Aug 24, 2001·The Journal of Biological Chemistry·H RizosR F Kefford
Sep 21, 2001·Nature·F P NoonanG Merlino

❮ Previous
Next ❯

Citations

Jan 24, 2004·Occupational and Environmental Medicine·B Perez-GomezG López-Abente
Aug 31, 2012·Hereditary Cancer in Clinical Practice·Maimoona SabirMahmood Akhtar Kayani
Jan 1, 2004·Hereditary Cancer in Clinical Practice·Tadeusz Debniak
Dec 3, 2013·European Journal of Cell Biology·Brigitte Bressac-de PailleretsCorine Bertolotto
Jul 16, 2014·Melanoma Research·Laura PergoliValentina Bollati
Jul 23, 2014·The American Journal of Dermatopathology·Paula C F SanchezCyro F Neto
Apr 7, 2012·Médecine sciences : M/S·Corine BertolottoBrigitte Bressac de Paillerets
Jul 28, 2012·Ocular Immunology and Inflammation·Nisha Nagarkatti-GudeChi-Chao Chan
Mar 22, 2003·Expert Review of Molecular Diagnostics·J Andrew CarlsonJeffrey S Ross
Aug 24, 2007·The Journal of Investigative Dermatology·Patricia Ashton-ProllaDavid Hogg
Dec 17, 2003·The Journal of Investigative Dermatology·Hongbing ShenQingyi Wei
Jun 16, 2009·The British Journal of Dermatology·A Larre BorgesS Puig
Sep 25, 2003·Genes, Chromosomes & Cancer·Caroline KannengiesserBrigitte Bressac-de-Paillerets
Feb 5, 2008·The British Journal of Dermatology·B Pérez-GómezM Pollán
Apr 3, 2007·International Journal of Cancer. Journal International Du Cancer·Alisa M GoldsteinBrigitte Bressac de-Paillerets
Sep 18, 2007·Clinical and Experimental Dermatology·N C DemirkanV Delmas
Jan 26, 2010·Actas dermo-sifiliográficas·S BloethnerR Kumar
Aug 21, 2013·Cancer Cell·Karoline KollmannVeronika Sexl
May 18, 2017·Genes & Development·Charlotte PandianiCorine Bertolotto
Jun 23, 2021·Curēus·Matthew G DaveyNiall M McInerney

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.